Verge Genomics
Leadership Approach Pipeline Partnerships News Careers
LeadershipApproachPipelinePartnershipsNewsCareers
Verge Genomics

32nd International Symposium on ALS/MND

We're pleased to be sharing new preclinical data from our #ALS#drugdiscovery program at the 32nd International Symposium on ALS/MND.

https://www.linkedin.com/feed/update/urn:li:activity:6874342531065348096/

EventsRob MaguireDecember 9, 2021
Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes
Previous

Verge Genomics Gets $98M to Take ALS Drug to the Clinic

NewsRob MaguireDecember 16, 2021
Next

32nd International Symposium on ALS/MND

EventsRob MaguireDecember 7, 2021
  • Home
  • Leadership
  • Approach
  • Pipeline
  • Accessibility
  • Partnerships
  • News
  • Careers
  • Privacy
Verge Genomics Logo

131 Oyster Point Blvd
Suite 300
South San Francisco
CA 94080

  • LinkedIn icon graphic
    X logo icon graphic
  • info@vergegenomics.com
Copyright 2023